A phase III, multicentre, randomised, double-blinded, placebo- controlled clinical trial of SpironolacTOne and famciclovir in Progressive Multiple Sclerosis: the STOP-MS trial

Project Details

StatusActive
Effective start/end date1/07/23 → 30/06/28

Funding

  • Medical Research Future Fund MRFF